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b2-Glycoprotein I (b2GPI) is a highly glycosylated phospholipid-binding
plasma protein comprised of four complement control protein (CCP)
domains and a distinct ﬁfth domain. The structural organisation of
human and bovine b2GPI in aqueous solution was studied by small-
angle X-ray scattering (SAXS). Low-resolution models that match the
SAXS experimental data best were independently constructed by three
different ab initio 3D-reconstruction algorithms. Similar elongated
S-shaped models with distinct side-arms, which were correlated to the
position of the carbohydrate chains, were restored from all three algor-
ithms. Due to an additional glycosylation site located on the CCP2 domain
of bovine b2GPI a small change in the characteristic SAXS parameters was
observed, which coincided with results obtained from SDS–PAGE. In
comparison to the human analogue the corresponding restored low-
resolution models displayed a similar S-shape with less bending in the
middle part.
As the experimental SAXS curves ﬁt poorly to the simulated scattering
curves calculated from the crystallographic coordinates of human b2GPI,
the crystal structure was modiﬁed. First, additional carbohydrate residues
missing from the crystal structure were modelled. Second, on the basis of
the low-resolution models, the J-shaped crystal structure was rotated
between CCP3 and CCP2 assuming the greatest interdomain ﬂexibility
between these domains. An S-shaped model with a tilt angle of ,608
between CCP3 and CCP2 yielded the best ﬁt to the experimental SAXS
data. Since there is evidence that b2GPI can adopt different conformations,
which reveal distinct differences in autoantibody recognition, our data
clearly point to a reorientation of the ﬂexible domains, which may be an
essential feature for binding of autoantibodies.
q 2002 Elsevier Science Ltd. All rights reserved
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Introduction
b2-Glycoprotein I (b2GPI), also designated as
apolipoprotein-H, is a plasma glycoprotein either
circulating free (0.2 mg/ml) or associated with
lipoprotein fractions.
1,2 In vitro studies have shown
that b2GPI plays a triggering role in the blood
coagulation cascade,
3 in platelet aggregation
4,5 and
in the course of thrombotic diseases.
3,6 b2GPI is a
highly glycosylated protein consisting of a single
polypeptide chain (326 amino acid residues) with
,19% (w/w) carbohydrates attached to N-linked
glycosylation sites.
7,8 An elongated J-shaped
arrangement of four complement control protein
(CCP) modules and a distinct C-terminal domain
V with overall protein dimensions of 13.2 nm £ 7.2
nm £ 2.0 nm was found by X-ray crystal-
lography.
9,10 The ﬁve domains are joined by short
interdomain linkers. The linkers are bordered by
two disulﬁde bonds and span only three (between
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other domains). The four N-terminal CCP domains
exhibit a conserved elliptically b-sandwich struc-
ture. They are highly homologous to each other
and to the other representatives of this super-
family. In contrast, domain V folds into a central
b-spiral with two small helices and carries a dis-
tinct positive charge in the proximity of the
surface-exposed loop region.
b2GPI shows a high afﬁnity for negatively
charged ligands, including heparin, DNA,
11 cell
membranes, endothelial cells,
12 macrophages
13 or
acidic phospholipids. Complexes formed by b2GPI
and acidic phospholipids were suggested to act
as antigens for autoimmune phospholipid auto-
antibodies (aPLAs) associated with clinical events
such as antiphospholipid syndrome, lupus
erythematosus, and recurrent fetal loss.
14–16 The
aberrant domain V is believed to bind to negatively
charged phospholipids,
17,18 whereas CCP1 and
CCP4 are suggested to comprise aPLAs binding
sites.
19–21 Recent studies reveal that the N-terminal
domains CCP1, CCP2, and CCP3 are involved in
the formation of speciﬁc protein clusters,
22,23
which can be recognized by aPLAs.
24 It has been
argued that, upon epitope exposure in a ligand-
associated state, the protein has a conformation
different from that in the water-soluble state,
21,25 in
which b2GPI displays a reduced immunological
activity.
26 To address this issue, we carried out
small-angle X-ray scattering (SAXS) experiments
of b2GPI in aqueous solution, and we have restored
three-dimensional structural models of b2GPI that
were compared to the crystal structure solved
recently by Bouma et al. and our group.
9,10 The
explicit differences of the overall shape between
crystal and solution structure are attributed to
carbohydrate units and to the ﬂexibility of the
CCP domains. The impact of a conceivable domain
reorientation with respect to immunological
activity and the structural differences between
human b2GPI and its bovine analogue are
discussed.
Results
Small-angle X-ray scattering parameters
SAXS raw data from human b2GPI (h-b2GPI) and
the ﬁnal desmeared SAXS proﬁles of h-b2GPI and
bovine b2GPI (b-b2GPI) are shown in Figure 1. The
radius of gyration (RG)o fb2GPI in aqueous solu-
tion decreases slightly with increasing concen-
tration in the range RG ¼ 4.3–4.1 nm for h-b2GPI
and RG ¼ 4.4–4.2 nm for b-b2GPI. This concen-
tration-dependence of the radii of gyration is
consistent with weak interparticular interactions.
After extrapolation to inﬁnite dilution, the ﬁnal
values of RG ¼ 4:30 nm for h-b2GPI and RG ¼
4:46 nm for b-b2GPI from the Guinier approxi-
mation are obtained. These values are in good
agreement with the RG values derived from the
p(r) function of the scattering proﬁles of the
extrapolated curves (see Table 1). The maximal
particle dimensions derived from RG and Rxs are
L ¼ 13:6 nm and 14.0 nm for h-b2GPI and b-b2GPI,
respectively. The scattering proﬁles for h-b2GPI
and b-b2GPI indicate similar shapes for both
proteins (r.m.s ¼ 0.04), which is seen also in the
distance distribution functions p(r)( Figure 1,
inset).
The molecular masses (MM), MM ¼ 53:5 kDa for
h-b2GPI and MM ¼ 58:0 kDa for b-b2GPI estimated
from I(0) are in good agreement with values
obtained from SDS–PAGE, i.e. 55.1 kDa and
58.1 kDa, respectively (Figure 2). The volumes
for the hydrated protein V ¼ 96 nm3 and V ¼
110 nm3 for h-b2GPI and b-b2GPI, respectively, are
close to the volumes obtained from low-resolution
models (see the next paragraph) and are twice the
dry volume Vd ¼ 46 nm3 calculated for the crystal
structure of h-b2GPI (1C1Z.pdb) (Table 1). A large
hydrated volume in comparison to the dry volume
is characteristic for elongated proteins.
27 In our
case, the hydrated volume is even enhanced by
the high glycosylation rate of b2GPI. It can thus be
concluded that the solution of b2GPI is mono-
disperse, and the scattering proﬁles can be further
used for ab initio shape analyses.
Figure 1. Experimental small-angle X-ray scattering
raw data of h-b2GPI (dots with error bars) and the ﬁnal
desmeared scattering proﬁles for h-b2GPI (dots) and
b-b2GPI (open circles) were processed as described in
Materials and Methods. The inset shows the distance dis-
tribution functions p(r)o fh - b2GPI (dots) and b-b2GPI
(open circles) evaluated by the program GNOM. The
arrows indicate the estimated values of Dmax obtained
from the p(r) function.
86 Solution Structure of b2GPITable 1. Experimental and model SAXS parameter
Human b2GPI Bovine b2GPI
Parameter Exp. DAMMIN
a DALAI_GA
a 1C1Z.pdb
b
1C1Z.pdb þ carbo-
hydrates (model 08)
b
1C1Z.pdb þ carbohydrates
þ rotation (model 1308)
b Exp. DAMMIN
a DALAI_GA
a
RG (nm) 4.30
c 4.26 ^ 0.01 4.21 ^ 0.03 4.61 4.48 4.29 4.46
c 4.34 ^ 0.08 4.33 ^ 0.06
RG ! p(r) (nm)
d 4.32 ^ 0.13 4.57 ^ 0.03 4.25 ^ 0.01 4.20 ^ 0.03 4.37 ^ 0.15
Rxs (nm)
e 1.78 1.42 1.75 1.70 1.88
L (nm)
f 13.6 15.2 14.3 13.6 14.0
Dmax ! p(r) (nm)
d 13.9 13.4 ^ 0.05 13.3 ^ 0.2 14.9 14.9 13.9 14.5 13.7 ^ 0.2 13.9 ^ 0.5
MM (kDa) 53.5 38.3 45.7 45.7 58.0
V (nm
3) 96 105 ^ 2 87 100 96 110 113 ^ 2
r.m.s 0.0040 ^ 0.0007 0.0017 ^ 0.0002 0.13 0.015 0.004 0.0019 ^ 0.0018 0.0026 ^ 0.0016
a The values given are the average and standard error from ten runs of the modelling algorithm.
b Scattering proﬁles up to qmax ¼ 2:6n m 21 and the parameters (RG, V, MM) for the atomic structures were calculated by the program CRYSOL with the radius of the atomic group ra ¼ 0:160 nm
and the contrast of the hydration layer of drb ¼ 60 e nm23:
c RG value was obtained after extrapolation to inﬁnite dilution; single values were calculated from Guinier ﬁt using a q range of 0.14–0.3 nm
21.
d RG and Dmax values were calculated from the p(r) function by the program GNOM.
e Rxs value was calculated from the cross-sectional Guinier ﬁt using a q range of 0.35–0.55 nm
21.
f Length of the particle L ¼½ 12ðR2
G 2 R2
xsÞ 1=2:Determination of low-resolution models for
human and bovine b2GPI
Overall shape restoration from solution scatter-
ing data for human and bovine b2GPI was
achieved by two different ab initio methods,
namely DAMMIN
28 and DALAI_GA.
29 In both pro-
cedures, only SAXS proﬁles up to qmax ¼ 2:6n m 21
for h-b2GPI and qmax ¼ 3:2n m 21 for b-b2GPI were
used for the ﬁts. In DAMMIN, ten independent
shape determinations were performed within a
spherical search volume of Dmax ¼ 14:0 nm for
both proteins. The packing radius of the dummy
atoms was 0.375 nm. The restored models for
h-b2GPI yield RG ¼ 4:26ð^0:01Þ nm; Dmax ¼
13:4ð^0:05Þ nm and V ¼ 105ð^2Þ nm3 and display
an S-like shape with a cross-section diameter of
about 2 nm, as expected for a CCP domain (Figure
3(a)). The restored models for b-b2GPI have
RG ¼ 4:34ð^0:08Þ nm; Dmax ¼ 13:7ð^0:2Þ nm and
V ¼ 113ð^2Þ nm3 (Figure 3(b)). The main structural
features are depicted by superposition of ﬁve
restored models with one template structure
(Figure 3(c) and (d)). Despite differences in the
structural details between the superimposed
models, consistence was achieved in the location
of side-arms, which are marked by arrows in the
Figure. The side-arms most probably indicate the
position of the N-linked carbohydrates attached to
the protein.
In DALAI_GA, the same scattering proﬁles
were used after manually subtracting a constant
according to Porod’s law for homogeneous par-
ticles in order to be consistent with DAMMIN,
where this is done automatically. Ten independent
shape determinations were performed within an
initial ellipsoidal search volume of a ¼ 15 nm; b ¼
c ¼ 8 nm for both proteins. The packing radius of
the dummy beads was 0.4 nm. The restored
models yielded RG ¼ 4:21ð^0:03Þ nm; Dmax ¼
13:3ð^0:1Þ nm and RG ¼ 4:25ð^0:06Þ nm; Dmax ¼
13:9ð^0:5Þ nm; for h-b2GPI and b-b2GPI, respec-
tively. A comparison with results from DAMMIN
illustrates that the individual models from
DALAI_GA are less packed, with more details
and signiﬁcantly reduced number of beads (Figure
4(a) and (b)). The observed differences in the com-
pactness are caused by the fact that no connectivity
restrictions during the shape determination were
used. The reduced number of beads, which results
in a smaller volume of the model, is caused by
differences in the calculation of the scattering
intensity by either the multiphase or the Debye
formula.
30 However, the ﬁve superimposed models
displayed in surface representation in Figure 4(c)
Figure 3. Low-resolution models restored by
DAMMIN. Single restored models of (a) h-b2GPI and
(b) b-b2GPI; on the right-hand side, the same model is
presented rotated clockwise by 908 along the Y axis. Five
superimposed different models of (c) h-b2GPI and
(d) b-b2GPI are displayed in surface representation; the
models at the bottom represent the same model rotated
clockwise by 908 about the Y axis. The arrows mark the
side-arms.
Figure 2. SDS–PAGE analysis of human b2GPI (lane 2)
and bovine b2GPI (lane 3). A sample of protein (1 mg)
was applied to each lane (12.5% (w/v) polyacrylamide
gel). Apparent molecular masses of 55.0 kDa for human
b2GPI and 58.1 kDa for bovine b2GPI were determined.
Lane 1: low molecular mass standard (Pharmacia).
88 Solution Structure of b2GPIand (d) reveal a remarkable similarity to the
models restored by DAMMIN.
As already mentioned, only the low-resolution
part of the scattering proﬁle (low angles) was
used to determine the shape of b2GPI. In order
to include the higher-resolution part of the X-ray
scattering pattern (up to qmax ¼ 4:0n m 21) for struc-
tural modelling, the program GASBOR
31 was used,
applying the modiﬁcations that are necessary for
a glycoprotein and are given in Materials and
Methods. This program ﬁts the experimental
scattering proﬁles successfully, with r.m.s values
of 0.013 ^ 0.01 and 0.029 ^ 0.02 for h-b2GPI and
b-b2GPI, respectively. For better illustration, Figure
5(a) and (b) presents a model for both proteins as
obtained by GASBOR shape determination. Again,
the overall shapes of the single restored models
are similar and resemble the models restored by
DAMMIN and DALAI_GA, as shown in Figures 3
and 4, respectively. Note the similarity in the
location of side-arms marked with arrows in
Figure 3(b) and (c) and with dark dots in Figure
5(a) and (b).
Modiﬁcation of the crystal structure of human
b2GPI based on the low-resolution models
The theoretical SAXS proﬁle and the p(r) func-
tion calculated from the crystallographic coordi-
nates of h-b2GPI (1C1Z.pdb) by the program
CRYSOL
32 are shown in Figure 6(a) and (b) (dotted
lines). First, the discrepancy (r.m.s ¼ 0.13) between
the calculated and the experimental scattering
proﬁles shows explicit differences. In general,
the shapes of the p(r) functions are typical for
elongated particles. However, the p(r) function
calculated for the crystal structure shows a higher
anisotropy in comparison to the p(r) function
obtained from solution experiments. The ﬁrst
maximum at r ¼ 1:9 nm in the p(r) function from
the crystal structure correlates well with the cross-
section value of the CCP domains. The maximum
of the p(r) functions from experimental data, how-
ever, is shifted to higher distances r , 3.8 nm,
whereas the ﬁrst maximum at r ¼ 1:9 nm is still
preserved as a shoulder. These results indicate
Figure 5. Single low-resolution models of (a) h-b2GPI
and(b) b-b2GPI restored by GASBOR. The models at the
bottom represent the same model rotated clockwise by
908 about the Y axis. The dark dots mark the side-arms.
Figure 4. Low-resolution models restored by
DALAI_GA. Single restored models of (a) h-b2GPI and
(b) b-b2GPI; on the right-hand side, the same model is
presented rotated clockwise by 908 about the Y axis.
Five superimposed different models of (c) h-b2GPI and
(d) b-b2GPI are displayed in surface representation; the
models at the bottom represent the same model rotated
clockwise by 908 about the Y axis.
Solution Structure of b2GPI 89that in comparison to the crystal structure the
solution structure of h-b2GPI is more bulky but
still elongated. Hence, it is essential to model the
carbohydrate residues that are missing from the
crystal structure. In particular, four carbohydrate
chains were attached to the residual carbohydrate
chains already detected in the crystal structure.
The carbohydrate chains were modelled in differ-
ent folding states, whereas the unfolded chain
with the highest solvent contact was determined
as the conﬁguration with the best ﬁt (r:m:s ¼
0:015) (Figure 6(a), broken line). A higher value
taken for the contrast of the hydration layer ðdrb ¼
60 e nm23Þ results in a further slight improvement
of the ﬁt in the high q-range of the scattering
curve. The corresponding p(r) function for the
Figure 6. (a) The theoretical scat-
tering proﬁles calculated from the
crystal structure of h-b2GPI, PDB-
code: 1C1Z (dotted line), the crystal
structure modiﬁed by adding
carbohydrate residues (broken
line), 1C1Z modiﬁed by rotating
the latter by 1308 (continuous line)
are ﬁt to the experimental scattering
proﬁle of h-b2GPI (open circles).
The theoretical scattering proﬁles
were calculated with a radius of
the atomic group ra ¼ 0:160 nm
and a contrast of the hydration
layer of drb ¼ 60 e=nm3 by the pro-
gram CRYSOL. (b) The correspond-
ing distance distribution functions
p(r) calculated by the program
GNOM. (c) RG (A) and r.m.s (B)
values calculated for 36 atomic
models modiﬁed by rotation of the
Ile121 backbone, where the rotation
angle is incremented in 108 steps,
whereas 08 rotation represents
the crystal structure modiﬁed by
adding carbohydrate residues. The
straight line depicts the experi-
mental RG value, RG ¼ 4:30 nm:
90 Solution Structure of b2GPImodiﬁed crystal structure with the added carbo-
hydrates is displayed in Figure 6(b) (broken line).
Although an improvement of the ﬁt to the experi-
mental data is achieved, a discrepancy for
q . 0.6 nm
21 is observed. In this q-range, however,
the inﬂuence of the scattering from the overall
structure is still dominant. In order to improve the
ﬁt, one has to take into account the bending of
the molecule. The differences in bending between
the low-resolution models and the crystal structure
most probably arise from different tilt and twist
angles between the CCP domains. Accordingly,
the crystal structure was rotated between domains
CCP3 and CCP2, a region where remarkably little
buried interface surface area was observed. The
Ile121 backbone, where the b-strand of the domain
linker shows a short random coil, was chosen as
the most suitable rotation bond between CCP3
and CCP2. The RG and r.m.s values calculated for
36 models, which differ in the rotation angle in
the Ile121 backbone, are shown in Figure 6(c). The
model with 08 rotation represents the modiﬁed
crystal structure with added carbohydrate chains.
The model with a rotation angle of 1308 shows the
best ﬁt to the experimental proﬁle ðr:m:s ¼ 0:004Þ
and the calculated RG value, RG ¼ 4:29 nm21; is
almost identical with the experimental value,
RG ¼ 4:30 nm21: The excellent ﬁt of the calculated
scattering proﬁle for the model rotated by 1308 to
the experimental data as well as the almost identi-
cal p(r) functions (Figure 6(a) and (b) continuous
lines) are a clear indication for a different bending
of h-b2GPI molecule in the crystal and in solution.
The ﬁnal model obtained by rotation (1308) dis-
plays an S-shaped structure (Figure 7) and closely
resembles the low-resolution models. The tilt
angle between CCP3 and CCP2 calculated for the
structure with the best ﬁt to the experimental
SAXS data is ,608, whereas from the crystal
structure an extremely low tilt angle of ,208 was
calculated. Additional evidence for the reliability
of the solution structure determination arises from
the fact that the calculated SAXS parameters (RG,
Dmax, V) for the rotated model are in much better
agreement with the experimental values (Table 1).
Table 1 shows the MM values calculated from the
crystal structure and from the models of h-b2GPI
in comparison to the experimental data. The MM
calculated for the crystal structure including the
carbohydrate chains is 45.7 kDa. This is consider-
ably less than the MM of 55.1 kDa estimated by
SDS-PAGE, which may be higher in the case of
glycoproteins.
33,34
Discussion
Differences between crystal and solution
structure of human b2GPI
The experimental scattering proﬁle ﬁt poorly to
the simulated curve calculated from the crystallo-
graphic coordinates of h-b2GPI. This fact, as well
as the disagreements in the corresponding p(r)
functions, indicate differences in the overall shape
of h-b2GPI in crystal and solution. From the SAXS
parameters in Table 1, it is obvious that the solu-
tion structure is less elongated and more bulky.
Due to the highly conserved structure of b2GPI
subunits (CCP domains þ domain V), changes in
the overall shape can be attributed to different
domain orientations only in the case of a mono-
meric solution. To obtain additional information,
three ab initio modelling approaches were applied
to ﬁt the experimental scattering proﬁle. The
corresponding low-resolution solution structural
models were restored. It should be noted that the
single models presented here show variations
between independent runs with similar goodness
of ﬁt and hence demonstrate that the SAXS shape
Figure 7. The crystal structure of
h-b2GPI (left) is shown in compari-
son to the atomic model with
complete carbohydrate chains and
transformed according to the best
ﬁt to the experimental data (right).
The secondary elements, b-strands
and a-helix of the structure are
shown as a continuous ribbon in
blue and red, respectively. The four
N-linked carbohydrates attached
to the residues Asn143, Asn164,
Asn174 and Asn234 drawn in all-
atom mode are: -GlcNAc-GlcNAc-
Man-(Man-GlcNAc-Gal-NeuAc)2
(GlcNAc, N-acetylglucosamine; Man,
mannose; Gal, galactose; NeuAc,
N-acetylneuraminic acid ! sialic
acid). The atomic model is addition-
ally displayed in transparent
surface presentation.
Solution Structure of b2GPI 91determination does not lead to unique solutions.
However, the superimposed models display a
consistent overall structure, which conﬁrms that
the information content in the scattering proﬁles
justiﬁes the ab initio modeling. Further, it should
be stressed that the models obtained by GASBOR
(Figure 5), although they display the location of C
a
atoms, are of low resolution, i.e. 1.6 nm, which is
deﬁned by the range of data ﬁtting. However, it
was possible to distinguish between main struc-
tural features and side-arms. The side-arms in the
models can be attributed to the carbohydrate units
attached to the asparagine residues 164, 174, and
234. These three carbohydrate units are in close
vicinity to each other, which results in a bulky
structural feature seen by SAXS. After attaching
the missing carbohydrates to the crystal structure,
a signiﬁcant improvement in the ﬁt of the calcu-
lated scattering proﬁle as well as of the p(r)
function of h-b2GPI to the experimental data was
achieved (Figure 6(a) and (b)). However, we
considered the ﬁt not sufﬁciently good. Accord-
ingly, the J-shaped crystal structure was modiﬁed,
applying a rotation at the most suitable inter-
domain linker bond (Ile121) (Figure 7). The analy-
sis of various models rotated in increments of 108
revealed that, in agreement with the low-resolution
models, an S-shaped structure shows the best ﬁt
to the experimental data. This model yields a tilt
angle of ,608 between CCP3 and CCP2, which is
in disagreement with the ,208 calculated from
the crystal structure. Low tilt angles of ,208 are
extremely rare,
35 whereas tilt angles of ,608 are
likely to be a common structural feature in proteins
with CCP domains, e.g. in human factor H (HFH
15–16 ¼ 50(^13)8),
36 measle virus binding protein
(CD46 1–2 ¼ 60(^15)8),
37 vaccinia virus protein
(VCP 3–4 ¼ 59(^4)8)
38 and in b2GPI between
CCP3–CCP4 (,608).
In conclusion, it can be postulated that under
nearly physiological conditions, b2GPI is more
bent and forms an averaged S-shaped solution
structure despite domain oscillations. However,
the exact characterization of the domain orien-
tation in a system of ﬁve domains connected with
four ﬂexible linkers is not reasonable. A potential
reason for an overall shape of h-b2GPI different
from the crystal structure might be the very high
ionic strength used during the crystallization pro-
cedure (I ¼ 6 M). High ionic strength destabilizes
the interdomain hydrogen bonds and, accordingly,
the crystal packing is dominated mainly by inter-
molecular hydrophobic interactions involving
CCP1, CCP2 and domain V, resulting in a J-shape.
The results presented here for h-b2GPI suggest
that crystallization conditions as well as the crystal
packing forces might affect the orientation of
protein subunits in the crystal.
Differences between human and bovine b2GPI
In view of the scattering proﬁles and the p(r)
functions shown in Figure 1, an overall shape simi-
larity between b-b2GPI and h-b2GPI is obvious.
Further evidence for a similar tertiary structure is
given by the 83% homology in the amino acid
sequence and the four characteristic CCP domains
with identical numbers of disulﬁde bonds followed
by one lipid-binding domain.
39 However, in the
present work, the small increase of size in the
experimental and model parameters for b-b2GPI
compared to h-b2GPI (Table 1) indicates a more
bulky shape of b-b2GPI. These results are in
good agreement with data from SDS–PAGE
(Figure 2) in which the molecular mass for
b-b2GPI was about 3 kDa higher compared to
h-b2GPI, probably caused by an additional Asn73
N-linked carbohydrate.
39 To summarize, the
restored low-resolution models of b-b2GPI dis-
played a similar S-shape with less bending in the
central part.
Functional implication
The structure of b2GPI in solution as presented
here exhibits a well deﬁned spatial orientation
and, due to the ﬂexibility of the interdomain
linkers, can adopt an optimal spatial and entropic
conformation through bending. However, the
structure is not necessarily conserved. For
example, in other cases, like in factor H, which is
composed of 20 CCP domains, the solution
structure exhibits a mixture of different domain
orientations driven by the fact that ﬁve longer
linkers (up to eight amino acid residues each)
permit a positional variation of the overall
structure.
40 Thus, proteins consisting of CCP or
similar domains can adopt different conformations,
where the variations depend critically on the ﬂexi-
bility and length of the linkers and on certain
spatial restrictions.
41,42
The solution structure determined for b2GPI
under nearly physiological conditions can put into
perspective different hypotheses for interaction of
b2GPI with membranes or aPLAs. In the literature,
some studies stress that binding of b2GPI to acidic
phospholipids alters the secondary structure of
the protein slightly, thus exposing autoepitopes,
21,25
whereas others advocate that dimerisation or
clustering of b2GPI
43,44 is essential for bivalent
binding of aPLAs.
45,46 Only recently, it was shown
that dimeric chimers of b2GPI have a much higher
afﬁnity for phospholipids.
24 From this point of
view, the solution structure represents the free,
not immobilized structure, which is described as
immunologically less active.
26 It is conceivable that
transitions between conformational states directly
correlate with the functional activity of the protein.
Immobilisation or cross-reacting of b2GPI domains
due to ligand binding
22 may cause the exposure of
cryptic epitopes
19–21,47 and reorientations of CCP-
domains, probably required for aPLAs interaction.
If so, this “bending” and “stretching” of the b2GPI
molecule could provide a mechanism for its
biological control.
92 Solution Structure of b2GPIDespite the limited resolution, SAXS is certainly
a useful tool to investigate the tertiary structure of
complex proteins in solution. This is of great
importance as the solution structure is sensitive to
conformational changes, which are fundamental
for the physiological role of a protein. In our case,
the structures of the glycoprotein obtained by
X-ray crystallography and solution scattering are
quite different. With the help of SAXS measure-
ments, we could model carbohydrate residues
that are not resolved in the crystal structure. By
analogy, this method could be applied to predict
the spatial orientation of a homologous struc-
ture that has is not been solved by X-ray
crystallography.
Materials and Methods
Protein isolation and puriﬁcation
b2GPI was isolated from citrated human or bovine
plasma as described.
1,48 In brief, the protein was puriﬁed
by afﬁnity column chromatography, dialysed exhaus-
tively against Tris–HCl (pH 7.4) and ﬁnally dialysed
against NH4HCO3 before lyophilization. The preparation
was virtually 100% pure as judged by SDS–PAGE, yield-
ing a single band with an apparent molecular mass
of 55.0 kDa for h-b2GPI and 58.1 kDa for b-b2GPI. The
protein was dissolved in 50 mM Tris–HCl (pH 7.4),
25 mM NaCl before use. The protein concentration was
measured by the bicinchoninic acid assay (BCA assay,
Pierce, The Netherlands).
Small-angle X-ray scattering
Measurements were carried out using a Kratky com-
pact camera (Hecus MBraun, Graz, Austria),
49 equipped
with a thermostatically controlled sample holder. The
measurements were performed at 20 8C using a quartz
capillary with a volume of 60 ml and an inner diameter
of 1.0 mm. Protein concentrations of 5, 10, 20, and
30 mg/ml were used. A Ni-ﬁltered primary X-ray beam
was generated by a water-cooled rotating Cu-anode
generator (Rigaku Corp., Japan). The sample to detector
distance was 272 mm and the position calibration of the
detector was performed using Ag-stearate as a standard.
Scattering curves were monitored in a q-range from 0.14
to 4.0 nm
21 ðq ¼ 4psin u=lÞ; with 2u being the scattering
angle and l ¼ 0:15418 nm (Cu Ka radiation) being the
wavelength of the X-ray. Exposure times were typically
3600 seconds for individual measurements. The scatter-
ing of the buffer was subtracted after absorption correc-
tion and the difference scattering curve was normalized
to a concentration of 1 mg/ml. The normalized curves
were extrapolated to zero concentration using standard
procedures.
50 The ﬁnal composite scattering curve
was obtained by merging the low-angle data
(0.14 , q , 0.8 nm
21) extrapolated to zero concentration
with the high-angle data (0.8 , q , 4.0 nm
21) recorded
at a high concentration (30 mg/ml). The resulting
scattering data were subjected to indirect Fourier trans-
formation using the program GNOM,
51 which performs
a desmearing of the raw data with the slit-width, and
slit length, proﬁles of the primary beam from the slit
collimation. Radii of gyration (RG) were further deter-
mined by Guinier approximation from the low q-regions
of the scattering proﬁles, yielding also the scattering
intensity extrapolated to the zero angle I(0):
50
ln IðqÞ¼ln Ið0Þ 2 R2
Gq2=3 ð1Þ
I(0) on a relative intensity scale was used to calculate the
molecular mass (MM)o fb2GPI using lysozyme with a
known MM of 14.4 kDa as a reference.
52,53 For elongated
particles, the mean radius of gyration of the cross-section
Rxs and the mean cross-sectional intensity at zero angle
[I(q)q]q!0 is obtained from:
ln½IðqÞq ¼ln½IðqÞq q!0 2 R2
xsq2=2 ð2Þ
RG and Rxs were used to analyze the triaxial dimensions
of b2GPI where the length of the particle is L ¼½ 12ðR2
G 2
R2
xsÞ 1=2: For an elongated particle, L < Dmax can be
assumed. The scattering proﬁles in the range up to
qmax ¼ 4:0n m 21 were used to compute the volumes V of
the hydrated particles.
50 V ¼ 2p2ðIð0Þ=QÞ; where Q is the
invariant according to Porod.
54 The program GNOM
was used to compute the pair-distance distribution func-
tion p(r), which represents the probability of ﬁnding a
point within the particle at a distance r from a given
point. Integrating this probability over the surface of the
sphere of radius R and over the volume V yields the
p(r) function as expressed by:
pðrÞ¼
1
2p2
ð1
0
rqIðqÞsinðrqÞdq ð3Þ
This offers an alternative calculation of RG and I(0) that is
based on the full scattering curve,
50 and gives the maxi-
mum dimension of the macromolecule Dmax, as the
distance where the p(r) function approaches zero.
Ab initio deconvolution of the SAXS proﬁle
The low-resolution shapes of b2GPI were restored
from the experimental data by two independent ab initio
shape-determination programs, DAMMIN
28 and
DALAI_GA.
29 Scattering proﬁles up to qmax ¼ 2:6n m 21
for human and qmax ¼ 3:2n m 21 for bovine b2GPI were
used for the ﬁt. DAMMIN calculates the scattering inten-
sities from a multiphase model of a particle built up from
a ﬁnite number of dummy beads that are characterized
by the conﬁguration vector assigning the beads to a
speciﬁc phase or to the solvent. DALAI_GA calculates
the scattering intensities of a given molecular structure
deﬁned by dummy beads (assuming the homogeneous
electron density) according to the Debye formula.
55
More detailed information about the approaches used
for the calculation of scattering intensity from beads
models can be found in the literature.
28,29 Each method
starts searching for a model in a volume ﬁlled by uni-
formly hexagonally packed beads with dimensions
selected according to the resolution of the scattering
proﬁle and taking into account the dimension of the
initial search object. DAMMIN searches for the best
model conﬁguration, minimizing the discrepancy func-
tion:
fðXÞ¼x2 þ aPðXÞð 4Þ
between the calculated and experimental curves using
the simulated annealing method.
56 Here, x is the dis-
crepancy between calculated and experimental curve,
and aP(X) is a looseness penalty with positive weight
a . 0. The idea of this method is to modify the coordi-
nates of beads randomly, while always approaching the
conﬁgurations that decrease the energy f(X). DALAI_GA
uses a genetic algorithm
57 for iterative ﬁtting of the
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population is generated randomly, within some restric-
tions, and for each model a ﬁtness value:
F ¼
X
i
ðlogðIexpðqiÞÞ 2 logðImodelðqiÞÞÞ2
 ! 21=2
ð5Þ
is assigned. The models are combined using genetic
operators in such a way that the better ﬁts have a higher
probability of “reproducing”. The repeated genetic
operators to the ﬁttest models increase the average
ﬁtness of the population. This process is repeated until
the system converges or a good enough model is found.
To improve the resolution and reliability of models, an
additional ab initio modelling approach, GASBOR was
used.
31 This procedure ﬁts the scattering proﬁles up to
qmax ¼ 4:0n m 21 and hence shows the highest resolution
for the b2GPI models ð2p=qmax ¼ 1:6n m Þ: GASBOR uses
a simulated annealing approach to ﬁnd a chain-com-
patible spatial distribution of an exact number of
dummy residues that corresponds to the distribution of
C
a atoms of amino acid residues. The calculation of the
scattering intensity from the model is based on the
Debye formula.
55 In this ﬁtting approach, the numbers
of amino acid residues of the protein have to be speci-
ﬁed. In the case of a glycoprotein, the contribution of
the scattering from carbohydrates has to be taken into
account. Due to different mean electron densities ðrÞ of
carbohydrates and proteins, the number of carbohydrate
residues has to be adjusted the following way in order
to be counted as amino acid residues
Nresidues ¼ Ncarbohydrate residuesðrcarbohydrate 2 rbufferÞ=
ðrprotein 2 rbufferÞ
ð6Þ
where Nresidues and Ncarbohydrate residues are the numbers of
amino acid residues and carbohydrate residues, respec-
tively. r of protein and buffer were set to rprotein ¼
447 e nm23 and rbuffer ¼ 334:5en m 23; respectively.
58
The rof carbohydrates can be calculated from  z(electron
concentration in e g
21) and the partial speciﬁc volume
(v2), according to
r ¼  zðv2Þ21NA £ 10221: ð7Þ
In particular, human b2GPI has four N-linked carbo-
hydrate units attached to the Asn residues 143, 164, 174,
234
9,10 (see the legend to Figure 7). Bovine b2GPI shows
glycosylation sites identical with that of an additional
site located on Asn73.
59 According to the deglycosylated
derivatives
60 prepared enzymatically, a similarity
between all carbohydrate units with a complex type
can be assumed. Nevertheless, the possibility of a
slight heterogeneity in sialylation cannot be excluded.
61
The electron concentration  z ¼ 0:534 e g21 and the
partial speciﬁc volume v2 ¼ 0:63 cm3 g2162 for the
carbohydrate units give the mean electron density of
rcarbohydrate ¼ 510:4en m 23: Applying equation (6), the
44 and 55 carbohydrate residues located in four
h-b2GPI and ﬁve b-b2GPI carbohydrate chains conse-
quently correspond to 69 and 86 amino acid residues,
respectively.
The goodness of ﬁt for all three above-mentioned ab
initio methods was measured using the root mean square
deviation (r.m.s) for N intensities I(q) according to:
r:m:s ¼
X N
i
ðlogðIexpðqiÞÞ 2 logðImodelðqiÞÞÞ2=N22
 !
ð8Þ
Application of theoretical SAXS proﬁles in crystal
structure modiﬁcation
The crystallographic coordinates with PDB-code
1C1Z
9 were used as an atomic model of human b2GPI.
The theoretical scattering curve from the crystal struc-
ture was calculated using the program CRYSOL,
32
which surrounds the macromolecule by a 0.3 nm thick
hydration layer with a slightly greater electron density
than the solvent.
63 The ﬁnal scattering intensity is
calculated as the addition of scattering of the particle in
vacuum and the hydration layer followed by subtraction
of scattering from the excluded volume. The program
either calculates the scattering proﬁle or ﬁts the experi-
mental data whenever the average excluded volume
per atomic group ra and the contrast of the hydration
layer drb are adjustable parameters to minimize the dis-
crepancy between experimental and calculated curves.
This ﬁtting approach was used to match the modiﬁ-
cations done within the crystal structure to the experi-
mental scattering proﬁle. Structural modiﬁcations
include rotation of CCP domains and attachment of
sugar units. The modiﬁcations were carried out using
the program WebLabViewerPro 4.0 (Accelrys Inc.).
Domain orientation
Domain orientations, speciﬁed by tilt angles, have
been evaluated for crystal and atomic models as follows.
For the CCP1 domain, the inertia tensor was calculated
and diagonalised. The main unitary vectors z with origin
in the center of mass were aligned along the major axes
of the inertia tensor. CCP domains 2–4 and domain
V were superimposed with CCP1. Superposition of
the CCP domains was performed by the program
SUPCOMB
64 using C
a positions of spatially related resi-
dues. The related unitary vectors z0 for each domain
were calculated from the transformation matrix obtained
by superimposing procedures. The tilt angle 1 between
neighbor domains is given by the angle cosð1Þ¼zz0
calculated for the neighbour domains. Deﬁnition of the
tilt angle 1 is according to Bork et al.
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